Organoclick AB (ORGC) — Capital Reinvestment Ratio

Latest as of June 2026: 0.11x

Organoclick AB (ORGC) has a Capital Reinvestment Ratio of 0.11x as of June 2026, meaning it reinvests 0% of its operating cash flow (Skr1.91 Million) in capital expenditures (Skr210.00K). Check tangible net worth ratio of Organoclick AB to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.11x
Capex / Operating Cash Flow

Operating Cash Flow

Skr1.91 Million
SEK

Capital Expenditures

Skr210.00K
SEK

Data as of

Jun 2026
Most recent filing

Organoclick AB Capital Reinvestment Ratio (2013–2024)

This chart tracks Organoclick AB's Capital Reinvestment Ratio across 4 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Organoclick AB.

Annual Capital Reinvestment Ratio for Organoclick AB (2013–2024)

Year-by-year Capital Reinvestment Ratio for Organoclick AB from 2013 to 2024. See how much free cash does Organoclick AB generate to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (SEK) Capital Expenditures YoY Change
2024 2.53x Skr3.60 Million Skr9.11 Million ▼ -84.3%
2023 16.15x Skr533.00K Skr8.61 Million ▲ +355.6%
2020 3.55x Skr5.47 Million Skr19.40 Million ▲ +1.4%
2013 3.50x Skr313.54K Skr1.10 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow